A patch test before full application is recommended, and anyone with Wilson's disease or who is pregnant should consult a healthcare professional before use
Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2018 and September 30, 2024
Establish a consistent storage routine: Designate a specific refrigerator location for diabetes medications, away from the freezer and door compartments Use a small container or bin to keep pens organized and visible Store pens in their original carton to protect from light Create a medication log noting when each pen was removed from refrigeration to track the 21-day room temperature window Implement safeguards against overnight incidents: Remember that tirzepatide is administered once weekly, not daily [1] Mark your calendar or set a recurring reminder for your weekly injection day Immediately return any unused pens to the refrigerator after taking out the pen you need for injection Use visual cues such as a note on your refrigerator reminding you to check for any pens left out Prepare for travel and routine disruptions: Purchase an insulated medication travel case with cooling elements for trips Request a small cooler bag from your pharmacy for transport from the pharmacy Plan ahead for weekly administration, especially when traveling across time zones Keep backup ice packs in your freezer for emergency cooling needs Educate household members about the importance of proper medication storage, especially if others access the refrigerator regularly
Join Circana for an upcoming webinar, The Ripple Effect of GLP-1s, Today and In the Future, on Wednesday, Jan
